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ABSTRACT 
Due to the unwholesome diet, sedentary life style, day by day our country is facing the increasing burden of the patients of diabetes induced high blood 
pressure, and obesity. Our country is becoming the capital of these diseases. These diseases mostly treated by allopathic medicines which are having 
considerable side effects and could not be used on long term basis. So conclusion is that in these disease, the dose of allopathic medicines and disease 
gradually progresses and in addition due to the side effects of allopathic medicines, it is better that these diseases should be treated by Ayurvedic 
medicines. 




High blood pressure (hypertension) is designated as either essential 
(primary) hypertension or secondary hypertension and is defined as a 
consistently elevated blood pressure exceeding 140/90 mm Hg. In 
essential hypertension (95% of people with hypertension) no specific 
cause is found. While secondary hypertension (5% of people with 
hypertension) is caused by an abnormality somewhere in the body 
such as in the kidney, adrenal gland & aortic artery etc. High blood 
pressure is called "the Silent Killer" because it often causes no 
symptoms for many years, even decades, until it finally damages 
certain critical organs like kidney, brain, blood vessel, eye etc.    Mostly 
its diagnosis is ruled out all of sudden when the person comes in 
contact of doctor or health worker etc. Heightened public awareness 
and screening of the population are necessary to detect hypertension 
early enough so it can be treated before critical organs are damaged. It 
is one of the major risk factors for cardiovascular mortality, which 
accounts for 20-25% of all deaths. 
Aims and objectives: 
1. To evaluate the efficacy of Ayurvedic drugs as compare to modern 
drug, like Atenolol 50 mg. 
2. To overcome the harmful effects of Allopathic drug in those patient 
which are suffering Diabetes (NIDDM) induced hypertension from long 
duration? 
Selection of Patients  
A total Ninety patient of Hypertension for clinical trial was screened 
out from OPD & IPD Government Ashtang College and local regional 
area of Lokmanya Nagar Indore M.P. 
Grouping of Patient: Screened patient or the case registered for the 
study were randomly divided into three groups 
Group A: This group of 30 patients will be given the trial of drug Vyan 
utkshepahara ghan vati Diabetes (NIDDM) induced hypertension. 
 
 
Group B: This group of 30 patients will be given the trial drug Atenolol 
50 mg.  
Group C: This group of 30 patients will be Placebo (VUHGV2)     
During the trial and follow up study the patients were assessed on the 
following parameter. 
 Inclusion criteria 
Patients with persistent rise of blood pressure with clinical picture of 
diabetes induced high blood pressure  have been selected for the 
research work. 
 Exclusion criteria 
Patients’ with severe grade of Hypertension. Mild or Moderate 
Hypertension associated with other diseases like Cardiomyopathy, 
Cardiac failure, Coronary artery disease, Heartblock, 
Cerebrovasculardisease,Encephalopathy,Preclampsia/eclampsia,Renal
disease,Diabetes mellitus and Retinopathy. 
Diagnostic criteria 
 To obtain diagnosis: On each occasion at least 2 sets of blood 
pressure reading, separated by 20-30 minutes intervals was taken. On 
the basis of 6th and 7th joint national committee on detection evaluation 
& treatment of high blood pressure. 
Subjective (clinical) Parameters 
JNC 6 Category  JNC 7 Category 
 SBP / DBP in mm Hg  
Optimal < 120 / 80  Normal  
Normal 
Border line 
120 – 129 / 80 – 84 
130 – 139 / 85-89  Pre hypertension 
Hypertension   140 / 90 Hypertension 
Stage 1 (mild) 
Stage2 (moderate) 
Stage 3 
140 – 159 / 90 – 99 
160 – 179 / 100 – 109 
 180 / 110 
 Stage I 
 
 Stage II 
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(Sweating) and Murchha (Syncope) symptoms have been screened for 
diagnosis of Hypertension. 
Assessment of Symptoms:  
Symptoms of the disease were assessed before and after the treatment 
on the basis of following criteria.  
Not Present/Absence of Symptom 0 0 
Very mild 1 25% 
Mild 2 50% 
Moderate 3 75% 
Severe 4 100% 
Assessment of Blood Pressure Reduction 
The results of the treatment were assessed as striking, wonderful, nice 
and fair at the end of treatment. The parameters of the assessment 
were taken as follows: - 
Striking: An excellent response to therapy when the fall in D.B.P. was 
found >20 mm Hg or more, S.B.P. >40 mm Hg. 
Wonderful: When the patient was noticed with a good response to 
therapy when fall in D.B.P. was found 11-20 mm Hg. S.B.P. was 21- 40 
mm. Hg. 
Nice: The response is named Nice when the fall in D.B.P. was 6 -10 m; 
S.B.P. was 11-20 mm. Hg. 
Fair: When the response falls in D.B.P. up to 5 mm Hg, S.B.P. was up to 
10 mm Hg. 
Objective (Laboratory) Parameters 
Complete Haemogram: Hb gm % TLC, DLC, ESR  
Biochemical examination: S.urea, S.creatinine, Blood sugar fasting 
Lipid profile ( S. cholesterol, S. triglyceride, S. HDL, S. LDL,S. VLDL 
ECG - The entire test mentioned here has been done before and after 
treatment. 
Ingredients of Vyan utkshepahara ghan vati 
Drug  Latin name  Proportion 
Shankhapushpi (convolvulus pluricaulis)  Equal part 
Punarnava  (Boerhavia diffusa)   " 
Vacha                      (Acorus calamus)   " 
Shunthi   (zingiber officinale)   " 
Kutaki   (Picrohiza Kurroa)   " 
Patol  (Trichoasathes dioica)  " 
Gugglu  (Commiphora mukul)  " 
Arjun  (Terminalia arjuna)   " 
Karela  (Momordia Charantia)  " 
Jamun  (Syzygium Cumini)   " 
Gudhchi  (Tinospora Cardifolia)  " 
PREPARATION OF TRIAL DRUG 
Vyan utkshepahara ghan vati: Vyan utkshepahara ghan vati was 
manufactured & standardized according to vati preparation method by 
classical method.  
Method of preparation: The coarse powder of the above mentioned 
quantity of drugs had been taken separately according to the number 
of patients & then Kasaya followed by Ghanasatva is prepared by 
classical method & then pills (each pill 500 mg) are prepared & dried. 
Dose                             -  1 gm BD 
Duration  -  2 months 
Anupana  -  Luke warm water 
Follow up: All the 90 patients of O.P.D. and I.P.D. level reviewed after 
two-month treatment. And on every review, blood pressure was 
measured in sitting posture for follow up records. Patients will be 
followed up after two month. 
Observation and Results 
The samples of 90 patients diabetes induced high blood pressure were 
selected and sub divided into 3 groups of 30 patients each. The 
treatment was observed according to the plan of the study. All the 
results were derived after execution of statistical techniques. The effect 
of each therapy is presented as follows: - 
Effect of Vyan utkshepahara ghan vati, Tab. Atenolol 50 mg and 
Placebo on S.B.P. 
Table No. : 1 Showing the statistically analysis of the effect of trial drug, control drug, and placebo on S.B.P. 
Group 
Mean 
Mean Diff. Mean % n SD SE t p Results 
BT AT 
A 159.67 145.53 14.14 8.85 30 13.07 2.39 5.91 <0.001 HS 
B 157.73 139.73 18.00 11.41 30 8.085 1.476 12.19 <0.001 HS 
C 156.6 153.03 3.56 2.27 30 12.12 2.21 1.61 <0.1 IS 
Note:  HS: Highly Significant, S: Significant, IS: Insignifican
In group A 30 patients were investigated for S.B.P. and an initial mean 
score of 159.67 mm of Hg was measured, after 2 month’s treatment of 
Vyan utkshepahara ghan vati, it reduced 145.53 mm of Hg with a mean 
difference of 14.14 mm of Hg with 8.85% of relief, it is highly 
significant  (t = 5.91, P<0.001). 
Group ‘B’30 patients were investigated for initial mean score of S.B.P. 
was measured 157.73 mm of Hg and it reduced to 139.73 mm of Hg 
with 2 month treatment of atenolol 50 mg and mean difference of 
18.00 mm of Hg and 11.41% of relief was observed. It is highly 
significant (t = 12.19, P<0.001). 
Initial mean score of Group C (for30 patients) S.B.P. was measured 
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156.6 mm of Hg and after 2 month treatment of placebo  is reduced to 
153.03 mm of Hg and a mean different of 3.56 mm of Hg was found and 
2.27% of relief was found. It is insignificant (t =1.61, P<0.1) 
Effect of Vyan utkshepahara ghan vati, Tab. Atenolol 50 mg and Placebo on D.B.P. 
Table 2: Showing the statistically analysis of the effect of Vyan utkshepahara ghan vati , Tab. Atenolol 50 mg and Placebo on D.B.P. 
Group 
Mean 
Mean Diff. Mean % n SD SE t p Results 
BT AT 
A 94.73 89.26 5.47 5.78 30 6.93 1.27 4.32 <0.001 HS 
B 95.40 88.20 7.20 7.55 30 4.830 0.882 8.16 <0.001 HS 
C 88.66 86.53 2.13 2.40 30 6.96 1.27 1.67 <0.1 IS 
 
In group A 30 patients were investigated for D.B.P. and an initial mean 
score of 94.73 mm of Hg D.B.P. was measured, after 2 month treatment 
of Vyan Utkshepahara Ghan Vati it reduced to 89.26 mm of Hg with a 
mean difference of 5.47 mm of Hg and 5.78% of relief. It is highly 
significant (t = 4.32, P<0.001). 
In group B’s initial mean score D.B.P. was measured 95.40 mm of Hg 
and it reduced to 88.20 mm of Hg with 2 month treatment of atenolol 
50mg  and mean difference of 7.20 mm of Hg and 7.55 % of relief was 
observed. It is highly Significant (t = 8.16, P<0.001) 
Initial mean score of group C’s D.B.P. was measured 88.66 mm of Hg 
and after 2 month treatment of placebo   is reduced to 86.53 mm of Hg 
and a mean difference of 2.13 mm of Hg was found and 2.40% of relief 















Table 3: showing mean percentage relief in Symptoms after two month clinical trial group,control group,and Placebo group. 
 
S. No. Group A Group B Group C 
Sirahshoola  72.2%, 82.2% 20.63% 
Bhrama  67.00% 83.13% 16.00% 
Tinnitus  52.17% 77.77% 9.00% 
Krodha  58.4% 61.9% 22.58% 
Klama  53.12% 59.00% 15.87% 
Hriddrava  58.33% 70.00% 14.28% 
Anidra  53.48% 62.63% 11.62% 
Swaskrichhrata  26.15% 61.90% 18.33% 
Nishamutrata  40.00% 55.55% 19.04% 
Bahumutrata  29.03% 58.49% 21.56% 
Atisweda  28.57% 50.00% 19.23% 
 
Table 4: show t value and P value of the symptoms after two month clinical trial (if P value<0.20 to >0.05=insignificant, if P value≤0.05 to   



















t value P value T value P value t value P value 
Sirahshoola 10.43 <.001 H.S 12.49 <.001 H.S 1.47 <.10 I.S 
Bhrama 9.74 <.001 H.S 12.81 <.001 H.S 1.58 <.10 I.S 
Tinnitus 6.00 <.001 H.S 6.42 <.001 H.S 0.75 <.10 I.S 
Krodha 9.34 <.001 H.S 12.80 <.001 H.S 1.66 <.10 I.S 
Klama 5.57 <.001 H.S 7.94 <.001 H.S 1.55 <.10 I.S 
Hriddrava 7.70 <.001 H.S 10.12 <.001 H.S 1.47 <.10 I.S 
Anidra 8.02 <.001 H.S 12.85 <.001 H.S 1.44 <.10 I.S 
Swaskrichhata 2.37 <.02 S 7.21 <.001 H.S 1.59 <.10 I.S 
Nishamutrata 2.87 <.02 S 5.00 <.001 H.S 1.17 <.20 I.S 
Bahumutrata 2.43 <.02 S 7.03 <.001 H.S 1.60 <.10 I.S 





Gupta et al. 
 











Mean % n SD SE t Results 
BT AT 
1. S. Cho. 175.73 158.53 17.2 9.78 30 17.40 3.17 5.41 <0.001 
2. S. Tg. 150.33 143.00 7.33 4.87 30 9.80 1.78 4.09 <0.001 
3. S. HDL 43.50 54.63 11.13 25.59 30 16.58 3.02 3.67 <0.001 
4. S. LDL 88.00 83.66 4.33 4.92 30 10.06 1.83 2.35 <0.02 
5. S. VLDL 33.56 30.1 3.46 10.32 30 8.88 1.62 2.13 <0.02 
6. S.Creatinine 0.79 0.73 0.06 7.94 30 0.239 0.043 1.44 <0.10 
7. S. Urea 32 28.66 3.33 10.41 30 10.30 1.88 1.77 <0.05 










Mean Diff. Mean % n SD SE t Results 
BT AT 
1. S. Cho. 171 166.4 4.6 2.69 30 16.64 3.03 1.51 <0.10 
2. S. Tg. 148.66 144.53 4.13 2.78 30 14.64 2.67 1.54 <0.10 
3. S. HDL 50.3 57.3 7.00 13.91 30 23.24 4.24 1.64 <0.10 
4. S. LDL 95.63 93.13 2.49 2.61 30 10.90 1.99 1.25 <0.20 
5. S. VLDL 33.56 30.8 2.76 8.24 30 9.63 1.75 1.57 <0.10 
6. S.Creatinine 0.783 0.76 0.023 2.97 30 0.116 0.021 1.09 <0.20 
7. S. Urea 32.06 29.13 2.93 9.14 30 10.32 1.88 1.55 <0.10 
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Mean Diff. Mean % n SD SE t Results 
BT AT 
1. S. Cho. 177.2 170.66 6.53 3.68 30 27.77 5.07 1.28 <0.20 
2. S. Tg. 148.66 145.2 3.46 2.33 30 15.28 2.79 1.24 <0.20 
3. S. HDL 57.46 54.5 2.96 5.16 30 13.37 2.44 1.21 <0.20 
4. S. LDL 95.66 93.63 2.03 2.12 30 10.99 2.00 1.01 <0.30 
5. S. VLDL 35.03 32.23 2.8 7.99 30 10.46 1.91 1.46 <0.10 
6. S.Creatinine 0.786 0.766 0.020 2.54 30 0.112 0.020 1.00 <0.30 
7. S. Urea 32.06 30.06 2.00 6.23 30 10.93 1.99 1.00 <0.30 











n SD SE t p Results 
BT AT 
A Hb gm% 11.77 11.98 0.21 1.84 30 0.806 0.147 1.47 <0.10 I.S 
B TLC 8046 7851 194 2.41 30 712 130 1.49 <0.10 I.S 
C ESR 16.06 14.53 1.53 9.54 30 4.33 0.791 1.93 <0.05 S 
 




Mean Diff. Mean % n SD SE t p Results 
BT AT 
A Hb gm% 11.83 12.08 0.25 2.11 30 0.858 0.156 1.59 <0.10 I.S 
B TLC 8004 7808 196 2.44 30 665.67 121.53 1.61 <0.10 I.S 
C ESR 16.2 14.53 1.66 10.28 30 4.46 0.815 2.04 <0.05 S 
 
Table 11: showing effect of Placebo on Hb,TLC & ESR group C. 
 
Biological values: After two month of trial there are no significant changes in Hb and TLC. Vyan utkshepahara ghan vati and Control drug Therapy 











Mean % n SD SE t p Results 
BT AT 
A Hb gm% 11.86 12.10 0.233 1.96 30 1.00 0.183 1.27 <0.20 I.S 
B TLC 8021 7886 135 1.68 30 614.76 112.24 1.20 <0.20 I.S 
C ESR 16.2 15.06 1.13 6.99 30 4.86 0.887 1.27 <0.20 I.S 
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Table 12: showing the Percentage of striking, wonderful, nice and fair in all three groups in S.B.P. 
 
S. No Response 
No. of Patients with reduction in SBP 
Group A         n=30 % Group B   n=30 % Group C   n=30 % 
1. Striking 9 30.00 15 50.00 0 00.00 
2. Wonderful 15 50.00 10 33.33 1 03.33 
3. Nice 5 16.66 4 13.33 2 06.66 
4. Fair 1 03.33 1 03.33 17 56.66 
5. No response 0 00.00 0 00.00 10 33.33 
 
Table 13: showing the Percentage of striking, wonderful, nice and fair in all three groups in D.B.P. 
  
S. No Response 
No. of Patients with reduction in DBP 
Group A         
n=30 
% 
Group B   
n=30 
% 
Group C   
n=30 
% 
1. Striking 8 26.66 16 53.33 0 00.00 
2. Wonderful 16 53.33 10 33.33 1 03.33 
3. Nice 4 13.33 3 10.00 2 06.66 
4. Fair 1 03.33 1 03.33 16 53.33 
5. No response 1 03.33 0 00.00 11 36.66 
 
DISCUSSION 
Ayurvedic treatment is a better remedy than Allopathic because 
generally Allopathic medicines are given after diagnosis of symptoms, 
whereas Ayurvedic remedies are given after analyzing the cause or root 
of the problem. To understand the various causes of hypertension from 
the Ayurvedic point of view it is necessary to understand its basic 
fundamental principles. Hypertension may also be classified according 
the main Dosha involved and its site of origin. The main site of Vata is 
the large intestine. When Vata and accumulates it can be absorbed into 
the blood increasing the qualities of Vata and causing constriction of 
the blood vessel walls. Constriction of the blood vessels may also be a 
result of Vata increasing due to psychological stress associated with 
fear, anxiety and insecurity. The small intestine is the main site of Pitta. 
If Pitta accumulates here it is absorbed into the circulatory system 
increasing the viscous, fatty oily qualities. Due to the increased 
viscosity, the blood exerts pressure on the blood vessels resulting in 
increased blood pressure. Pitta can also increase due to psychological 
stress related to anger, hate, envy and jealousy may be associated with 
increase blood pressure.Kapha type hypertension originates in the 
stomach being the main site of Kapha. Kledaka Kapha produced in the 
stomach in the form of gastric mucosal secretions that are responsible 
for the digestion of carbohydrates, starch and glucose. The end 
products of this phase are tryglycerides. When Kledaka Kapha is 
disturbed or there is an accumulation of Kapha at this site, there is an  
accumulation of triglycerides and cholesterol. This accumulation of 
Kapha predominant qualities then move into the circulatory system 
causing an increase in the viscosity of plasma tissue within the blood 
resulting in increased pressure on the blood vessels.Ayurveda 
recognizes that the mind has a strong influence on the heart. If an 
individual is under psychological stress, this can lead to the onset of 
hypertension. Mental tension accumulates in the physical body via the 
brain which is the gateway between the mind and body. This function 
is governed by Prana Vayu and controls the autonomic nervous system 
which is responsible for blood pressure regulation. The brain normally 
programs the body by sending excitatory and inhibitory impulses to 
certain areas, and by regulating the balance of the autonomic and 
sensory motor components of the nervous system. When Prana Vayu is 
disturbed, hypertension can occur due to excessive sympathetic 
stimulation. Disturbed Prana Vayu also relates to all psychosomatic 
diseases which are caused by the unbalancing and disorganization of 
mental processes that proceed as though they were disconnected from 
our control. Hypertension may also be a result of heredity and lifestyle 
due to developed mental patterns of unwholesome living habits which  
 
 
affect the circuits of the brain leading to hypertension. The perception 
or  mind  can  affect  our  body’s  response  and  lead  to  a  balanced or 
imbalanced state of health. Environmental stimulus creates impression 
on the mind which leads to psychological response effects on the body 
altering the following centres: 
1-Limbic system 2-Hypothalamus 3-Neuroendocrine system 4-Long 
term Effect on Body 5-Altered Immune Function 
An important factor to be considered when establishing the cause and 
reason for the manifestation of disease in a particular part of the body 
is the concept of Khavaigunya. Khavaigunya corresponds to a Dhatu or 
area of the body being more susceptible to disease or imbalance. This 
helps to understand why a particular tissue is affected and its 
origin.For example there may be a genetic predisposition in the family 
(Beej Doshaja),long standing or acute exposure to environmental, 
physical or psychological stressors causing the tissue to be inherently 
weak or weakened, which explains why that particular site has become 
vitiated. Therefore any disease can be caused by one particular Dosha 
or a combination of the three. When the Dosha’s become aggravated 
through food, lifestyle or attitude, the nature of that substance leads to 
an increase of similar qualities inherent in the body and mind. The 
accumulation of these qualities according to Ayurveda is first stage of 
disease. 
In more than 95% of cases of specific underlying causes of 
hypertension cannot be found (essential hypertension) the 
pathogenesis of essential hypertension is not clearly understood. Non 
modifiable risk factor like age, sex, genetic factor, ethnicity & 
modifiable risk factor like obesity salt intake, Saturated fat, alcohol, 
heart rate, physical activity, environmental stress, socioeconomic 
status, dietary fibers & other factor explain approximately 40 - 60 %. 
5% of hypertensive patient have identifiable causes like endocrinal 
(Diabetes) renal, cardiovascular disease, & drugs induce etc. 
Hence the constituents of these drugs are selected in a holistic 
approach for Diabetic induced hypertensive patients.    
Shankhapushpi (convolvulus pluricaulis)-help to treat stress induced 
hypertension (C.N.S origin) 
Punarnava (Boerhavia diffusa) - help to treat renal induced 
hypertension 
Vacha (Acorus calamus) help to treat stress induced hypertension 
(C.N.S origin) 
Shunthi (zingiber officinale) - help to treat Toxins   induced 
hypertension 
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Kutaki (Picrohiza Kurroa) help to treat Blood volume induced 
hypertension. 
Patol (Trichoasathes dioica) help to treat Diabetic induced 
hypertension 
Gugglu (Commiphora mukul) - help to treat Obesity induced 
hypertension 
Arjun (Terminalia arjuna) - help to treat cardiac induced hypertension 
Karela (Momordia Charantia) - help to treat Diabetic induced 
hypertension 
Jamun (Syzygium Cumini) - help to treat Diabetic induced 
hypertension 
Gudhchi (Tinospora Cardifolia) - help to treat auto immune induced 
hypertension 
Dipana – Pacana drugs it is clear that Agnimandya is a prime factor for 
production of Hypertension. Dipana pacana drugs (Shunthi etc) 
improve the status of Agni.  
Lekhana drugs having Srotosodhaka & weight reducing properties 
which help to treatment of hypertension. (Drugs like Guggulu Kutaki 
etc)  
Virechana: Kostha suddhi is very importance in treating a patient of 
Hypertension. The elimination of Doshas and Mala from body by 
Virechana karma, Virechana karma reduce the increase blood volume 
induced Hypertension. (Example Kutaki) 
Tridosha samana: Hypertension is Tridoshaja vyadhi but most vitiated 
and dominant Doshas are vata & kapha, those drugs which have 
Tridoshsamaka properties use to treat hypertensive patient (Drug like 
Shunthi)  
Rasayana Therapy:Rasayna help to protect Oja. Improve Agni,cleans 
the microcirulatory channels etc. all these developments help in 
producing tranquility of mind and thus reducing Hypertension, 
Rasayans (Chawanprash etc)  increase the Medha (Buddhi) is called 
Medhya (drugs like shankhpuspi  jatamansi etc.) help  to treat stress 
induced hypertension.  
Srotosodhana: Rasayan like Guduchi etc.Mutrala Drugs (Diuretics like 
punarnava) Reduce the vascular volume by diuresis which ultimately 
influence the blood pressure. 
Hridya drugs (Cardiotonic) these drugs increase oja & Avalambaka 
Kapha. & are beneficial for heart is known as Hridya like Arjun etc. Uses 
of Antidiabetic drug like Karela in case of Diabetic induced 
Hypertension .Uses of guggulu preparation for obesity induced 
hypertension. 
The result of the final study reveals better efficacy of Vyan 
utkshepahara ghan Vati. Fruther correlation in terms of S. Creatinine, 
S.Urea,and S.cholesterol etc. also confirms the efficacy of Vyan 
utkshepahara ghan Vati. The efficacy of Vyan utkshepahara ghan Vati in 
hypertension has been due to its ingredients; shankhpuspi, punarnava, 
vacha, shunthi, kutaki, patol, gugglu, arjuna, karela, jamun 
shankhpusphpi, punarnava, vacha, shunthi, kutaki, patol, gugglu, arjuna, 
karela, jamun and gudhchi directly or indirectly affects on blood 
pressure. The desired Pharmacological effect also shows the genuine 
nature of medicament. The present study being of explanatory nature 
no firm reacting result can be desired. Further study in this respect 
shall have the way to pin point role of all the drugs in Hypertension.  
CONCLUSION 
In all the three groups, group A (Diabetes (NIDDM) induced 
hypertension) was found as the most benefited group because it 
showed significant as well as highly significant changes in symptoms 
and Biochemistry investigations. Whereas Group B (control group) 
showed significant as well as highly significant changes in symptoms 
but not in Biochemistry investigations. Placebo showed insignificant 
changes in both.  
The drug Vyan utkshepahara ghan vati is a safe herbal formulation and 
has shown encouraging results in the management of Diabetes 
(NIDDM) induced hypertension on various scientific parameters.  
While Vyan utkshepahara ghan vati”reduced both systolic and diastolic 
pressure in a more pronounced way, Furthermore, it was also found 
during treatment that some of patients improved to such an extent that 
they had either stopped the modern antihypertensive drug completely 
or minimized its dose suggesting that the drug.  Thus being helpful in 
avoiding the side effects of modern drug too.   
The plus point observed in case of Ayurvedic management is absence of 
any hazardous effect, which is really a great benefit to the patient. 
It offers the possibility of effectiveness & very well tolerated therapy 
ensuring reliability & good acceptance in use therefore on point of 
view of Ayurvedic treatment by Vyan utkshepahara ghan vati may be 
accepted as the drug of choice in the case of mild and moderate 
Diabetes (NIDDM) induced hypertension.     
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